Correlation Between APELLIS PHARMACTDL and Corporate Travel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both APELLIS PHARMACTDL and Corporate Travel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining APELLIS PHARMACTDL and Corporate Travel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between APELLIS PHARMACTDL 0001 and Corporate Travel Management, you can compare the effects of market volatilities on APELLIS PHARMACTDL and Corporate Travel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in APELLIS PHARMACTDL with a short position of Corporate Travel. Check out your portfolio center. Please also check ongoing floating volatility patterns of APELLIS PHARMACTDL and Corporate Travel.

Diversification Opportunities for APELLIS PHARMACTDL and Corporate Travel

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between APELLIS and Corporate is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding APELLIS PHARMACTDL 0001 and Corporate Travel Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corporate Travel Man and APELLIS PHARMACTDL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on APELLIS PHARMACTDL 0001 are associated (or correlated) with Corporate Travel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corporate Travel Man has no effect on the direction of APELLIS PHARMACTDL i.e., APELLIS PHARMACTDL and Corporate Travel go up and down completely randomly.

Pair Corralation between APELLIS PHARMACTDL and Corporate Travel

Assuming the 90 days horizon APELLIS PHARMACTDL 0001 is expected to under-perform the Corporate Travel. In addition to that, APELLIS PHARMACTDL is 1.32 times more volatile than Corporate Travel Management. It trades about -0.22 of its total potential returns per unit of risk. Corporate Travel Management is currently generating about -0.16 per unit of volatility. If you would invest  805.00  in Corporate Travel Management on October 16, 2024 and sell it today you would lose (55.00) from holding Corporate Travel Management or give up 6.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

APELLIS PHARMACTDL 0001  vs.  Corporate Travel Management

 Performance 
       Timeline  
APELLIS PHARMACTDL 0001 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in APELLIS PHARMACTDL 0001 are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, APELLIS PHARMACTDL reported solid returns over the last few months and may actually be approaching a breakup point.
Corporate Travel Man 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Corporate Travel Management are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Corporate Travel is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

APELLIS PHARMACTDL and Corporate Travel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with APELLIS PHARMACTDL and Corporate Travel

The main advantage of trading using opposite APELLIS PHARMACTDL and Corporate Travel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if APELLIS PHARMACTDL position performs unexpectedly, Corporate Travel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corporate Travel will offset losses from the drop in Corporate Travel's long position.
The idea behind APELLIS PHARMACTDL 0001 and Corporate Travel Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments